A growing list of defined tumor-antigens opens the way to antigen specific immunotherapy of
cancer. However current approaches are often limited in their potential to induce an effective …

Dendritic cells (DCs) are the most potent professional antigen-presenting cells (APCs), and
are capable of stimulating naive T cells and driving primary immune responses. Due to this …

The ability of immune therapies to control cancer has recently generated intense interest.
This therapeutic outcome is reliant on T cell recognition of tumour cells. The natural function …

Dendritic cells (DCs) are considered as professional antigen presenting cells (APCs),
containing a variety of subsets, that can be resident in organs or migrating among the …

Dendritic cells (DCs) are specialized immunostimulatory cells involved in the induction and
regulation of immune responses. The feasibility of large-scale ex vivo generation of DCs …

The interplay between host immunity and tumour cells has opened the possibility of
targeting tumour cells by modulation of the human immune system. Cancer immunotherapy …

Dendritic cell (DC) vaccination in cancer patients aims to induce or augment an effective
antitumor immune response against tumor antigens and was first explored in a clinical trial …

Importance of the field: Dendritic cells (DC) are powerful antigen-presenting cells that induce
and maintain primary cytotoxic T lymphocyte (CTL) responses directed against tumor …

Despite initial enthusiasm, dendritic cell (DC)‐based anti‐cancer vaccines have yet to live
up to their promise as one of the best hopes for generating effective anti‐tumor immunity …

Dendritic cells (DCs) play a crucial role in the initiation and regulation of the antitumor
immune response. Already, DC-based antitumor vaccines have been thoroughly explored …